Cardiac Biomarkers TestingMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications
Discover trends, market shifts, and competitive outlooks for the cardiac biomarkers testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Are the Key Projections for the CAGR of the Cardiac Biomarkers Testing Market Size From 2025 to 2034?
The sector for cardiac biomarkers testing has experienced swift expansion in the past few years. The market is projected to surge from $13.48 billion in 2024 to $15.09 billion in 2025, showing a compound annual growth rate (CAGR) of 12.0%. The past growth can be credited to various factors such as the rising occurrence of heart-related diseases, a growing elderly population, increased awareness and educational programs, government actions and healthcare regulations, along with an upsurge in healthcare spending.
Expectations are high for a swift expansion of the cardiac biomarkers testing market in the coming years. The projections suggest that the market will reach a size of $23.75 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. The growth drivers for this period include the rise in personalized medicine, the increasing global impact of cardiovascular diseases, the incorporation of artificial intelligence in diagnostic procedures, the growth of point-of-care testing, and heightened focus on early disease detection. Key trends for the forecast window are expected to be technological innovations, progress in AI-aided diagnostics, point-of-care testing (POCT) expansion, multiplexing capabilities, and breakthroughs in biomarker discovery and validation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Cardiac Biomarkers Testing Market?
The growth of the cardiac biomarkers testing market is projected to accelerate due to the rising occurrence of cardiovascular illnesses. These are conditions that have an impact on the heart or blood vessels. The purpose of cardiac biomarker tests is to immediately ascertain the severity and scale of a heart attack by gauging the levels of biomarkers. Thus, as the prevalence of cardiovascular diseases rises, so does the demand for cardiac biomarker testing solutions. For example, the American College of Cardiology, a US-based medical professional organization, predicted in August 2022 that the rates of cardiovascular disease and risk factors are expected to significantly increase in the United States by 2060. Consequently, the growing prevalence of cardiovascular diseases is fueling the expansion of the cardiac biomarkers testing market.
Which Primary Segments of the Cardiac Biomarkers Testing Market Are Driving Growth and Industry Transformations?
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp
Which Regions Are Key Players in the Growth of the Cardiac Biomarkers Testing Market?
North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Cardiac Biomarkers Testing Market?
Prominent firms involved in the cardiac biomarker testing market are leveraging strategic collaborations to offer technology that aids in early detection of heart condition symptoms, thus enhancing patient results. These alliances encourage cooperation between corporations within the cardiac biomarker testing market, fostering the creation of novel diagnostic methods, expanding market accessibility, and hastening the availability of avant-garde solutions for superior cardiovascular care. For example, MediBuddy, an Indian health tech firm that provides a holistic platform for telemedicine, health management, and insurance support, collaborated with the Netherlands-based conglomerate, Philips, in September 2024. Through this alliance, they aspire to enrich cardiac healthcare in India using Philips’ HeartPrint technology, which allows for regular heart health monitoring and risk evaluation. This progressive strategy equips users of the MediBuddy platform with high-tech tools, promoting proactive heart health management and improved results.
View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
What Parameters Are Used to Define the Cardiac Biomarkers Testing Market?
Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
